Strata Critical Medical (NASDAQ:SRTA) Announces Quarterly Earnings Results

Strata Critical Medical (NASDAQ:SRTAGet Free Report) released its earnings results on Wednesday. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.07, FiscalAI reports. The company had revenue of $67.38 million for the quarter. Strata Critical Medical had a net margin of 20.97% and a negative return on equity of 5.92%.

Strata Critical Medical Price Performance

Shares of SRTA stock traded down $0.10 during trading hours on Thursday, hitting $5.23. The company’s stock had a trading volume of 673,650 shares, compared to its average volume of 820,590. The company has a market capitalization of $454.61 million, a P/E ratio of 10.72 and a beta of 2.15. Strata Critical Medical has a 12-month low of $2.84 and a 12-month high of $6.02.

Analysts Set New Price Targets

Several research firms have weighed in on SRTA. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. Weiss Ratings began coverage on shares of Strata Critical Medical in a research report on Tuesday, March 24th. They set a “hold (c-)” rating on the stock. B. Riley Financial began coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price on the stock. Finally, Craig Hallum assumed coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $8.00.

Read Our Latest Analysis on SRTA

Institutional Trading of Strata Critical Medical

Large investors have recently made changes to their positions in the business. Granite Investment Partners LLC boosted its holdings in shares of Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after acquiring an additional 7,911 shares during the last quarter. Seelaus Asset Management LLC boosted its holdings in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after acquiring an additional 6,000 shares during the last quarter. Finally, Principal Financial Group Inc. purchased a new stake in Strata Critical Medical during the first quarter worth $537,000. 47.36% of the stock is owned by hedge funds and other institutional investors.

About Strata Critical Medical

(Get Free Report)

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Read More

Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.